NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|267339|sp|P18450|]
View 

RecName: Full=Spike glycoprotein; Short=S glycoprotein; AltName: Full=E2; AltName: Full=Peplomer protein; Flags: Precursor

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
TGEV-like_Spike_SD1-2_S1-S2_S2 cd22377
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
677-1410 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from transmissible gastroenteritis virus and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine transmissible gastroenteritis virus (TGEV), canine coronavirus (CCoV), and feline coronavirus (FCoV). They display greater than 96% sequence identity and have been grouped in the same species, alphacoronavirus 1, within the Alphacoronavirus genus. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


:

Pssm-ID: 411964 [Multi-domain]  Cd Length: 751  Bit Score: 1229.63  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    677 DLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITS 756
Cdd:cd22377    1 DISVLVKDECTDYNIYGFQGTGIIRNTTSRLVAGLYYTSISGDLLAFKNSTTGEIFTVVPCDLTAQAAVINDEIVGAITS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    757 INSE-----------------LLGLTHWTTTPNFYYYSIYNytndmtrgtaiDSNDVDCEPVITYSNIGVCKNGALVFIN 819
Cdd:cd22377   81 VNQTdlfefvnhtqsrrsrrsTLGLVHTYTMPQFYYITKWN-----------NDTSTNCTSVITYSSFAICNTGEIKYVN 149
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    820 VTHSDGDV------QPISTGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVG 893
Cdd:cd22377  150 VTHVEIVDdsigviKPISTGNITIPKNFTVAVQAEYIQIQVKPVVVDCAKYVCNGNRHCLKLLTQYTSACQTIENALNLG 229
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    894 ARLENMEVDSMLFVSENALKLASVEAFNSSETLDPiykewpNIGGSWLEGLKYILPSDNSKRkyrSAIEDLLFSKVVTSG 973
Cdd:cd22377  230 ARLESLMLNDMITVSDRSLELATVEKFNSTVLGGE------KLGGFYFDGLKDLLPPRIGKR---SAIEDLLFNKVVTSG 300
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    974 LGTVDEDYKRCTGGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGAlGGGAVAIPFAVAVQARLNYVALQ 1053
Cdd:cd22377  301 LGTVDDDYKKCSAGTDVADLVCAQYYNGIMVLPGVVDDNKMAMYTASLIGGMALGS-ITSAVAVPFAMQVQARLNYVALQ 379
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1054 TDVLNKNQQILASAFNQAIGNITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSIS 1133
Cdd:cd22377  380 TDVLQENQKILANAFNNAIGNITLALGKVSNAITTTSDGFNTMASALTKIQSVVNQQGEALSQLTSQLQKNFQAISSSIA 459
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1134 DIYNRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPN 1213
Cdd:cd22377  460 EIYNRLEKVEADAQVDRLITGRLAALNAYVSQTLTQYAEVKASRQLAMEKVNECVKSQSDRYGFCGNGTHLFSLVNSAPD 539
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1214 GMIFFHAVLLPTAYETVTAWAGICALDGDRTFGLvvkdVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFV 1293
Cdd:cd22377  540 GLLFFHTVLLPTEWEEVTAWSGICVNDTYAYVLK----DFLTSIFSYNGTYMVTPRNMFQPRKPQMSDFVQITSCEVTFL 615
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1294 NATLSDLPSIIPDYIDINQTVQDILENFRPNWTVPE--LTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNIN 1371
Cdd:cd22377  616 NTTYTTFQEIVIDYIDINKTIADMLEQYNPNYTVPEldLQLEIFNQTKLNLTAEIDQLEQRADNLTNIAHELQQYIDNLN 695
                        730       740       750
                 ....*....|....*....|....*....|....*....
gi 267339   1372 NTLVNLEWLNRIETYVKWPWYVWLLIGLVVIFCIPLLLF 1410
Cdd:cd22377  696 KTLVDLEWLNRIETYVKWPWYVWLLIGLVVVFCIPLLLF 734
CoV_S1 pfam01600
Coronavirus spike glycoprotein S1; This family represents the spike glycoprotein (S) of ...
249-670 2.49e-158

Coronavirus spike glycoprotein S1; This family represents the spike glycoprotein (S) of coronaviruses. The spike protein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. This entry contains spike protein from both alpha and gamma coronaviruses but excludes the spike protein from beta-coronaviruses such as SARS-CoV.


:

Pssm-ID: 460262  Cd Length: 412  Bit Score: 484.15  E-value: 2.49e-158
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      249 SNCTDqCASYVANVFTTQPGGFIPSDFSFNNWFLLTNSSTLVSGKLVTKQPLLVNCLWPVPSFEEAASTFCFEGAG-FDQ 327
Cdd:pfam01600    2 SVCTN-CDGFPDNVFAVEEGGYIPPSFSFNNWFYLTNSSTPVDGRVVSNQPLLLNCLWPIPSLNGTTLKVYFNGSIpNGR 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      328 CNGA-VLNNTVDVIRFNLNFTTNVQSGKGATVFSLNTTGGVTLEISCYNDTVSDSSFSsygEIPFGVTDGPRYCYVLYNG 406
Cdd:pfam01600   81 CNGYsNKNGTVDAIRFNLNFTASDSVFAGAGSISLNTVGGVTYSFSCSNSSTPVGASH---QIPFGATDQPYYCFVNYNG 157
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      407 ---TALKYLGTLPPSVKEIAISKWGHFYINGYNFFSTFPIDCISFNLTTGDSDVFWTIAYTSYTEALVQVENTAITKVTY 483
Cdd:pfam01600  158 nisTTSQFVGILPPVVREIVISRYGDFYVNGYRYFSTPPLESVNFNLTSGDTSDFWTVAFANYTDVLVNINNTSIQRILY 237
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      484 CNSYVNNIKCSQLTANLNNGFYPVSSSEVGFVNKSVVLLPTFYTHTIVNITIGLGMKrSGYGQPIASTLSNITLPMQDNN 563
Cdd:pfam01600  238 CDSPLNSIKCQQLSFSLPDGFYSTSSVEVVQLPRTFVTLPKFATHSFVNLTVSVSFD-GGGGPPSLSALSEVNLTINGTN 316
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      564 IDVYCIRSDQFSVYVHSTCKSAlwdnvfkrnctdVLDATAVIKTGTCPFSFDKLNNYLTFNKFCLSLSPVGANCKFDV-A 642
Cdd:pfam01600  317 NTSLCVNTSQFTVNLNFTCTST------------AYGYTAEIRTGTCPFSFDKLNNYLSFGSICFSLVPSGGGCTMDIvT 384
                          410       420
                   ....*....|....*....|....*...
gi 267339      643 ARTRANDQVVRSLYVIYEEGDNIVGVPS 670
Cdd:pfam01600  385 KYWNGSFVKVGSLYVSYSEGDNITGVPK 412
 
Name Accession Description Interval E-value
TGEV-like_Spike_SD1-2_S1-S2_S2 cd22377
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
677-1410 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from transmissible gastroenteritis virus and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine transmissible gastroenteritis virus (TGEV), canine coronavirus (CCoV), and feline coronavirus (FCoV). They display greater than 96% sequence identity and have been grouped in the same species, alphacoronavirus 1, within the Alphacoronavirus genus. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411964 [Multi-domain]  Cd Length: 751  Bit Score: 1229.63  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    677 DLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITS 756
Cdd:cd22377    1 DISVLVKDECTDYNIYGFQGTGIIRNTTSRLVAGLYYTSISGDLLAFKNSTTGEIFTVVPCDLTAQAAVINDEIVGAITS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    757 INSE-----------------LLGLTHWTTTPNFYYYSIYNytndmtrgtaiDSNDVDCEPVITYSNIGVCKNGALVFIN 819
Cdd:cd22377   81 VNQTdlfefvnhtqsrrsrrsTLGLVHTYTMPQFYYITKWN-----------NDTSTNCTSVITYSSFAICNTGEIKYVN 149
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    820 VTHSDGDV------QPISTGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVG 893
Cdd:cd22377  150 VTHVEIVDdsigviKPISTGNITIPKNFTVAVQAEYIQIQVKPVVVDCAKYVCNGNRHCLKLLTQYTSACQTIENALNLG 229
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    894 ARLENMEVDSMLFVSENALKLASVEAFNSSETLDPiykewpNIGGSWLEGLKYILPSDNSKRkyrSAIEDLLFSKVVTSG 973
Cdd:cd22377  230 ARLESLMLNDMITVSDRSLELATVEKFNSTVLGGE------KLGGFYFDGLKDLLPPRIGKR---SAIEDLLFNKVVTSG 300
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    974 LGTVDEDYKRCTGGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGAlGGGAVAIPFAVAVQARLNYVALQ 1053
Cdd:cd22377  301 LGTVDDDYKKCSAGTDVADLVCAQYYNGIMVLPGVVDDNKMAMYTASLIGGMALGS-ITSAVAVPFAMQVQARLNYVALQ 379
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1054 TDVLNKNQQILASAFNQAIGNITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSIS 1133
Cdd:cd22377  380 TDVLQENQKILANAFNNAIGNITLALGKVSNAITTTSDGFNTMASALTKIQSVVNQQGEALSQLTSQLQKNFQAISSSIA 459
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1134 DIYNRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPN 1213
Cdd:cd22377  460 EIYNRLEKVEADAQVDRLITGRLAALNAYVSQTLTQYAEVKASRQLAMEKVNECVKSQSDRYGFCGNGTHLFSLVNSAPD 539
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1214 GMIFFHAVLLPTAYETVTAWAGICALDGDRTFGLvvkdVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFV 1293
Cdd:cd22377  540 GLLFFHTVLLPTEWEEVTAWSGICVNDTYAYVLK----DFLTSIFSYNGTYMVTPRNMFQPRKPQMSDFVQITSCEVTFL 615
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1294 NATLSDLPSIIPDYIDINQTVQDILENFRPNWTVPE--LTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNIN 1371
Cdd:cd22377  616 NTTYTTFQEIVIDYIDINKTIADMLEQYNPNYTVPEldLQLEIFNQTKLNLTAEIDQLEQRADNLTNIAHELQQYIDNLN 695
                        730       740       750
                 ....*....|....*....|....*....|....*....
gi 267339   1372 NTLVNLEWLNRIETYVKWPWYVWLLIGLVVIFCIPLLLF 1410
Cdd:cd22377  696 KTLVDLEWLNRIETYVKWPWYVWLLIGLVVVFCIPLLLF 734
CoV_S2 pfam01601
Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic ...
833-1388 0e+00

Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic 'corona' after which the group is named. The Spike glycoprotein is translated as a large polypeptide that is subsequently cleaved to S1 pfam01600 and S2,. The S2 subunit normally contains multiple key components, including one or more fusion peptides (FP), a second proteolytic site (S2') and two conserved heptad repeats (HRs), driving membrane penetration and virus-cell fusion. The HRs can trimerize into a coiled-coil structure built of three HR1-HR2 helical hairpins presenting as a canonical six-helix bundle and drag the virus envelope and the host cell bilayer into close proximity, preparing for fusion to occur.


Pssm-ID: 460263  Cd Length: 502  Bit Score: 767.20  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      833 GNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSMLFVSENAL 912
Cdd:pfam01601    1 GNISIPTNFTISVQTEYIQTTSPKVSVDCAQYVCNGNERCLQLLVQYGSFCSTIEQALQGSARLEDVEVLSMLSISNRAL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      913 KLASVEAFNSSEtldpiykewpniggswleGLKYILPSDNSkrkYRSAIEDLLFSKVVTSGLGTVDeDYKRCTGGYDIAD 992
Cdd:pfam01601   81 TLATISNFGSDF------------------NFSSFLPCLNS---GRSAIEDLLFDKVVTSGLGTVD-AYKKCTKGTSIAD 138
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      993 LVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAI 1072
Cdd:pfam01601  139 LVCAQYYNGIMVLPGVVDAEKMAMYTASLTGGMAFGGLTGAAAAIPFALAVQARLNYLGLQTDVLQENQKILANAFNNAV 218
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339     1073 GNITQsfgkvndaihqtsrGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLI 1152
Cdd:pfam01601  219 GNITD--------------GFTTTASALSKIQDVVNANAQALNQLTQQLSNNFGAISSSIQDIYSRLDQLEADAQVDRLI 284
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339     1153 TGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYETVTA 1232
Cdd:pfam01601  285 NGRLAALNAFVTQQLTKASEVKASRQLAQQKVNECVKSQSSRYGFCGNGTHLFSLPQAAPNGIMFLHTVLVPTEYITVKA 364
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339     1233 WAGICAldgDRTFGLVVKDVQLTLFRNldDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYIDINQ 1312
Cdd:pfam01601  365 TPGLCV---NGTTGYAPRDGQFVLNNT--SNWYITPRNMYQPRPITGSDFVQISSCDVNFVNITNTKLPPLIPDYVDFNK 439
                          490       500       510       520       530       540       550
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 267339     1313 TVQDILENFrpNWTVPELTFDIFNATYLNLTGEIDDLEfrseklhnttvELAILIDNINNTLVNLEWLNRIETYVK 1388
Cdd:pfam01601  440 ELEDIYKNL--NSTLPDLDLDIFNATILNLTDEIKDLE-----------RLQELIDNLNQTLVDLEWLNRYETYIK 502
CoV_S1 pfam01600
Coronavirus spike glycoprotein S1; This family represents the spike glycoprotein (S) of ...
249-670 2.49e-158

Coronavirus spike glycoprotein S1; This family represents the spike glycoprotein (S) of coronaviruses. The spike protein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. This entry contains spike protein from both alpha and gamma coronaviruses but excludes the spike protein from beta-coronaviruses such as SARS-CoV.


Pssm-ID: 460262  Cd Length: 412  Bit Score: 484.15  E-value: 2.49e-158
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      249 SNCTDqCASYVANVFTTQPGGFIPSDFSFNNWFLLTNSSTLVSGKLVTKQPLLVNCLWPVPSFEEAASTFCFEGAG-FDQ 327
Cdd:pfam01600    2 SVCTN-CDGFPDNVFAVEEGGYIPPSFSFNNWFYLTNSSTPVDGRVVSNQPLLLNCLWPIPSLNGTTLKVYFNGSIpNGR 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      328 CNGA-VLNNTVDVIRFNLNFTTNVQSGKGATVFSLNTTGGVTLEISCYNDTVSDSSFSsygEIPFGVTDGPRYCYVLYNG 406
Cdd:pfam01600   81 CNGYsNKNGTVDAIRFNLNFTASDSVFAGAGSISLNTVGGVTYSFSCSNSSTPVGASH---QIPFGATDQPYYCFVNYNG 157
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      407 ---TALKYLGTLPPSVKEIAISKWGHFYINGYNFFSTFPIDCISFNLTTGDSDVFWTIAYTSYTEALVQVENTAITKVTY 483
Cdd:pfam01600  158 nisTTSQFVGILPPVVREIVISRYGDFYVNGYRYFSTPPLESVNFNLTSGDTSDFWTVAFANYTDVLVNINNTSIQRILY 237
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      484 CNSYVNNIKCSQLTANLNNGFYPVSSSEVGFVNKSVVLLPTFYTHTIVNITIGLGMKrSGYGQPIASTLSNITLPMQDNN 563
Cdd:pfam01600  238 CDSPLNSIKCQQLSFSLPDGFYSTSSVEVVQLPRTFVTLPKFATHSFVNLTVSVSFD-GGGGPPSLSALSEVNLTINGTN 316
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      564 IDVYCIRSDQFSVYVHSTCKSAlwdnvfkrnctdVLDATAVIKTGTCPFSFDKLNNYLTFNKFCLSLSPVGANCKFDV-A 642
Cdd:pfam01600  317 NTSLCVNTSQFTVNLNFTCTST------------AYGYTAEIRTGTCPFSFDKLNNYLSFGSICFSLVPSGGGCTMDIvT 384
                          410       420
                   ....*....|....*....|....*...
gi 267339      643 ARTRANDQVVRSLYVIYEEGDNIVGVPS 670
Cdd:pfam01600  385 KYWNGSFVKVGSLYVSYSEGDNITGVPK 412
PHA03332 PHA03332
membrane glycoprotein; Provisional
1008-1193 8.48e-03

membrane glycoprotein; Provisional


Pssm-ID: 223047 [Multi-domain]  Cd Length: 1328  Bit Score: 40.72  E-value: 8.48e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    1008 VANADKMT---MYTASLAGGI-TLGALGGGAVAIPFAVAVQARLNYvALQTDVLNKNQQILAsafnqaigniTQSFGKVN 1083
Cdd:PHA03332  829 VLDLWHETvkmFAPRRFGGSVmAGDAIGLSAAAFTMASAALNAATQ-ALAVATLYVNQLLQA----------TAATAEMA 897
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    1084 DAIHQTSRglatvakALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDE--LSADAHVDRLITGrLTALNA 1161
Cdd:PHA03332  898 SKIGGLNA-------RVDKTSDVITKLGDTIAKISATLDNNIRAVNGRVSDLEDQVNLrfLAVATNFNTLATQ-LKELGT 969
                         170       180       190
                  ....*....|....*....|....*....|..
gi 267339    1162 FVSQTLTRQAEVRASRQLAKDKVNECVRSQSQ 1193
Cdd:PHA03332  970 TTNERIEEVMAAALYYQQLNSLTNQVTQSASK 1001
 
Name Accession Description Interval E-value
TGEV-like_Spike_SD1-2_S1-S2_S2 cd22377
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
677-1410 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from transmissible gastroenteritis virus and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine transmissible gastroenteritis virus (TGEV), canine coronavirus (CCoV), and feline coronavirus (FCoV). They display greater than 96% sequence identity and have been grouped in the same species, alphacoronavirus 1, within the Alphacoronavirus genus. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411964 [Multi-domain]  Cd Length: 751  Bit Score: 1229.63  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    677 DLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITS 756
Cdd:cd22377    1 DISVLVKDECTDYNIYGFQGTGIIRNTTSRLVAGLYYTSISGDLLAFKNSTTGEIFTVVPCDLTAQAAVINDEIVGAITS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    757 INSE-----------------LLGLTHWTTTPNFYYYSIYNytndmtrgtaiDSNDVDCEPVITYSNIGVCKNGALVFIN 819
Cdd:cd22377   81 VNQTdlfefvnhtqsrrsrrsTLGLVHTYTMPQFYYITKWN-----------NDTSTNCTSVITYSSFAICNTGEIKYVN 149
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    820 VTHSDGDV------QPISTGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVG 893
Cdd:cd22377  150 VTHVEIVDdsigviKPISTGNITIPKNFTVAVQAEYIQIQVKPVVVDCAKYVCNGNRHCLKLLTQYTSACQTIENALNLG 229
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    894 ARLENMEVDSMLFVSENALKLASVEAFNSSETLDPiykewpNIGGSWLEGLKYILPSDNSKRkyrSAIEDLLFSKVVTSG 973
Cdd:cd22377  230 ARLESLMLNDMITVSDRSLELATVEKFNSTVLGGE------KLGGFYFDGLKDLLPPRIGKR---SAIEDLLFNKVVTSG 300
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    974 LGTVDEDYKRCTGGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGAlGGGAVAIPFAVAVQARLNYVALQ 1053
Cdd:cd22377  301 LGTVDDDYKKCSAGTDVADLVCAQYYNGIMVLPGVVDDNKMAMYTASLIGGMALGS-ITSAVAVPFAMQVQARLNYVALQ 379
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1054 TDVLNKNQQILASAFNQAIGNITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSIS 1133
Cdd:cd22377  380 TDVLQENQKILANAFNNAIGNITLALGKVSNAITTTSDGFNTMASALTKIQSVVNQQGEALSQLTSQLQKNFQAISSSIA 459
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1134 DIYNRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPN 1213
Cdd:cd22377  460 EIYNRLEKVEADAQVDRLITGRLAALNAYVSQTLTQYAEVKASRQLAMEKVNECVKSQSDRYGFCGNGTHLFSLVNSAPD 539
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1214 GMIFFHAVLLPTAYETVTAWAGICALDGDRTFGLvvkdVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFV 1293
Cdd:cd22377  540 GLLFFHTVLLPTEWEEVTAWSGICVNDTYAYVLK----DFLTSIFSYNGTYMVTPRNMFQPRKPQMSDFVQITSCEVTFL 615
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1294 NATLSDLPSIIPDYIDINQTVQDILENFRPNWTVPE--LTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNIN 1371
Cdd:cd22377  616 NTTYTTFQEIVIDYIDINKTIADMLEQYNPNYTVPEldLQLEIFNQTKLNLTAEIDQLEQRADNLTNIAHELQQYIDNLN 695
                        730       740       750
                 ....*....|....*....|....*....|....*....
gi 267339   1372 NTLVNLEWLNRIETYVKWPWYVWLLIGLVVIFCIPLLLF 1410
Cdd:cd22377  696 KTLVDLEWLNRIETYVKWPWYVWLLIGLVVVFCIPLLLF 734
alphaCoV_Spike_SD1-2_S1-S2_S2 cd22369
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
677-1380 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) protein from alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses including human coronaviruses (HCoVs), HCoV-NL63, and HCoV-229E, and porcine coronaviruses, transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV), among others. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1 the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411956 [Multi-domain]  Cd Length: 666  Bit Score: 1149.34  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    677 DLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITS 756
Cdd:cd22369    1 DPSVVHLNVCTDYTIYGITGRGIIRKSNSTYIAGLYYTSNSGQLLGFKNSTTGEVFSVTPCQLSSQVAVVSDNIVGVMSA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    757 INSELLGLTHWTTTPNFYYYSIynytndmtrgtaidsNDVDC-EPVITYSNIGVCKNGALV-FINVTHSDGDVQPISTGN 834
Cdd:cd22369   81 TNNVSLGFNNTIETPSFYYHSN---------------GAENCtEPVLTYGSIGVCADGSITeVTPRSVSPEPVSPIITGN 145
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    835 VTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSMLFVSENALKL 914
Cdd:cd22369  146 ISIPSNFTVSVQVEYLQMYLKPVSVDCSTYVCNGNPRCLQLLTQYASACRTIEEALQLSARLESVEVNSMITVSEEALRL 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    915 ASV----EAFNSSETLDPIYKewpniggswleglkyilpsdnskrkYRSAIEDLLFSKVVTSGLGTVDEDYKRCTGGYDI 990
Cdd:cd22369  226 ANIstffDDYNLSAVLPAGVG-------------------------GRSAIEDLLFDKVVTSGLGTVDEDYKACTKGLGI 280
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    991 A--DLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAvAIPFAVAVQARLNYVALQTDVLNKNQQILASAF 1068
Cdd:cd22369  281 AaaDVACAQYYNGIMVLPGVVDAEKMALYTASLTGGMVLGGFTAAA-AIPFSLAVQSRLNYVALQTDVLQRNQQILANSF 359
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1069 NQAIGNITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHV 1148
Cdd:cd22369  360 NSAMGNITVAFSEVNDAIQQTSDAINTVAQALNKVQNVVNEQGQALSQLTKQLASNFQAISSSIEDIYNRLDGLAADAQV 439
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1149 DRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYE 1228
Cdd:cd22369  440 DRLITGRLAALNAFVTQTLTKYTEVRASRQLAQQKINECVKSQSSRYGFCGNGTHLFSIVNAAPDGIMFLHTVLLPTEYV 519
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1229 TVTAWAGICaLDGDrtfGLVVKDVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYI 1308
Cdd:cd22369  520 TVAAWAGLC-VDGK---AYVLRDDVVLTLFKLNDKYYVTPRDMFEPRVPVSSDFVQISNCNVTYVNITSDELPEVIPDYI 595
                        650       660       670       680       690       700       710
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 267339   1309 DINQTVQDILENfRPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWL 1380
Cdd:cd22369  596 DVNKTLEEFLAN-LPNYTLPDLPLDIFNATYLNLTGEIADLENKSESLLNTTVELQELIDNINNTLVDLEWL 666
PDEV-like_Spike_SD1-2_S1-2_S2 cd22376
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
677-1385 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Porcine epidemic diarrhea virus and related alphacoronavirus; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses, including porcine epidemic diarrhea virus (PEDV), Scotophilus bat coronavirus, and swine enteric coronavirus, among others. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1 the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411963 [Multi-domain]  Cd Length: 673  Bit Score: 963.06  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    677 DLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITS 756
Cdd:cd22376    1 DVSFMTLDVCTKYTIYGFKGEGIITLTNSSLLGGVYYTSDSGQLLAFKNVTSGAIYSVTPCSFSQQAAYVDDDIVGVISS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    757 INSELLGLThwTTTPNFYYYSiynytNDMTRGTaidsndvdcEPVITYSNIGVCKNGALVFINVTHSDGDVQPISTGNVT 836
Cdd:cd22376   81 LSNSTFNST--RELPGFFYHS-----NDGSNCT---------EPVLVYSNIGVCKSGSIGYVPSQSGQPKIAPMVTGNIS 144
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    837 IPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSMLFVSENALKLAS 916
Cdd:cd22376  145 IPTNFTMSIRTEYLQLYNTPVSVDCAMYVCNGNSRCKQLLTQYTSACKTIESALQLSARLESVEVNSMLTISEEALQLAT 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    917 VEAFNssetldpiykewpniGGSWleGLKYILPSDNSKRkyrSAIEDLLFSKVVTSGLGTVDEDYKRCTGGYDIADLVCA 996
Cdd:cd22376  225 ISSFN---------------GGGY--NFTNVLGASVQKR---SFIEDLLFNKVVTNGLGTVDEDYKRCSNGLSVADLVCA 284
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    997 QYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAvAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAIGNIT 1076
Cdd:cd22376  285 QYYSGVMVLPGVVDAEKLHMYSASLIGGMVLGGITAAA-ALPFSYAVQARLNYVALQTDVLQRNQQLLAESFNSAIGNIT 363
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1077 QSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLITGRL 1156
Cdd:cd22376  364 SAFESVKEAISQTSQGLNTVAHALTKVQDVVNSQGAALNQLTVQLQHNFQAISSSIDDIYSRLDQLSADAQVDRLITGRL 443
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1157 TALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGN-GTHLFSLANAAPNGMIFFHAVLLPTAYETVTAWAG 1235
Cdd:cd22376  444 SALNAFVAQTLTKYTEVQASRKLAQQKVNECVKSQSQRYGFCGGdGEHIFSLVQAAPQGLLFLHTVLVPGDFVNVTAIAG 523
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1236 ICAldgDRTFGLVVKDVQLTLFRNL----DDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYIDIN 1311
Cdd:cd22376  524 LCV---DDEIALTLREPGVLFTHEVltytATEYFVSPRKMFEPRKPTVSDFVQIESCVVTYVNLTSDQLPDVIPDYIDVN 600
                        650       660       670       680       690       700       710
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 267339   1312 QTVQDILENFrPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIET 1385
Cdd:cd22376  601 KTLDEILASL-PNRTGPSLPLDVFNATYLNLTGEIADLEQRSESLRNTTEELRSLIYNINNTLVDLEWLNRVET 673
delta-PiCoV-like_Spike_SD1-2_S1-S2_S2 cd22374
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
659-1401 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Pigeon coronavirus UAE-HKU29, and related avian deltacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Pigeon coronavirus UAE-HKU29, and related avian deltacoronaviruses including Falcon coronavirus UAE-HKU27, Magpie-robin coronavirus HKU18, Sparrow coronavirus HKU17, and Night heron coronavirus HKU19. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the (C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411961 [Multi-domain]  Cd Length: 739  Bit Score: 898.09  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    659 YEEGDNIVGVPSDNSGLHDLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCD 738
Cdd:cd22374    1 YQPGNSITAMPQPSTGTTDISTVYLDVCTKYNIYGKTGTGIIRLTNQSYIAGLYYTSPSGDLLAFKNVTTQTVYSVTPCR 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    739 VSAQAAVIDGTIVGAITSI-NSELLGLTHWTTTPNFYYYSIynytndmtrgtaidSNDVDCEPVITYSNIGVCKNGALVF 817
Cdd:cd22374   81 LSSQVAVYNGSIIAAFTSTeNFTIADFTYSRATPMFYYHSI--------------GNDTCETPVITFGSIGVCPGGGLHF 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    818 INVTHSDGD-VQPISTGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARL 896
Cdd:cd22374  147 VDPTSNEFTnVVPISTQNISIPKNFTVSIQTEYIQIEQQPVTVDCRQYVCNGNPRCLQLLMQYTSACSTIEQALSLNARL 226
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    897 ENMEVDSMLFVSENALKLASVEAFNSSetldpiykewpNIGGSwlegLKYILPSDNSKRkyrSAIEDLLFSKVVTSGLGT 976
Cdd:cd22374  227 EAASIQTMLTYSPETLKLANITNFQSD-----------DVNYN----LTNILPKKYQGR---SAIEDLLFDKVVTNGLGT 288
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    977 VDEDYKRCTGGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAvAIPFAVAVQARLNYVALQTDV 1056
Cdd:cd22374  289 VDQDYKACTNGVSIADLVCAQYYNGIMVLPGVADPEKMAQYTASLTGGMVFGGLTSAA-AIPFSLAVQSRLNYVALQTDV 367
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1057 LNKNQQILASAFNQAIGNITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIY 1136
Cdd:cd22374  368 LQQNQQILADSFNNAMGNITLAFKEVSEGLSQVSGAITTVANALTKIQTVVNSQGQALATLTEQLANNFQAISASIADIY 447
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1137 NRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMI 1216
Cdd:cd22374  448 NRLNQLEADAQVDRLITGRLAALNAFVTQTLSKLAEVRQARQLALDKINECVKSQSSRYGFCGNGTHLFSIVNAAPYGFV 527
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1217 FFHAVLLPTAYETVTAWAGICALDgdrtFGLVVKDVQLTLFRNlDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNAT 1296
Cdd:cd22374  528 FFHTVLLPTQYATVQAYSGICQNG----RALALKDPSLALFRG-TDKYLVTPRNMYQPRTAAQADFVYIESCTVTYLNLT 602
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1297 LSDLPSIIPDYIDINQTVQDILENFrPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVN 1376
Cdd:cd22374  603 DTTIDAVIPDYVDVNKTVEDILNNL-PNYTKPDLDIGRYNNTILNLTTEINDLNGRAENLSQIVENLEEYIKKINATLVD 681
                        730       740
                 ....*....|....*....|....*
gi 267339   1377 LEWLNRIETYVKWPWYVWLLIGLVV 1401
Cdd:cd22374  682 LEWLNRVETYIKWPWWVWLLIALAI 706
HCoV-NL63-229E-like_Spike_SD1-2_S1-S2_S2 cd22375
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
677-1388 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoproteins from HCoV-NL63, HCoV-229E, and related alphacoronavirus; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses, including human coronaviruses (HCoVs), HCoV-NL63 and HCoV-229E. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411962 [Multi-domain]  Cd Length: 677  Bit Score: 865.37  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    677 DLSVLHLDSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITS 756
Cdd:cd22375    1 SFSNVVLNNCTKYNIYDYSGTGVIRSSNDSFIGGITYTSNSGNLLGFKDVSTGTIYSITPCNPPDQVVVYQQAIVGAMLS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    757 INSELLGLTHWTTTPNFYYYSiyNYTNDMTrgtaidsndvdcEPVITYSNIGVCKNGALVFI---NVthSDGDVQPISTG 833
Cdd:cd22375   81 ENETRYGLSNVVELPNFYYAS--NGTYNCT------------DAVLTYSNFGICADGSIIPVrprNV--SDNGVSAIVTA 144
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    834 NVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSMLFVSENALK 913
Cdd:cd22375  145 NLSIPSNWTTSVQVEYLQITSTPIVVDCSTYVCNGNPRCVELLKQYTSACKTIEDALRLSARLESADVSSMLTFDSNAFT 224
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    914 LASVEAFnssetldpiykewpniGGSWLEGLKYILPSDNSKRKYRSAIEDLLFSKVVTSGLGTVDEDYKRCTGGYDIADL 993
Cdd:cd22375  225 LANVSSF----------------GDYNLSSVLPQLPTSGSRIAGRSAIEDLLFSKVVTSGLGTVDADYKSCTKGLSIADL 288
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    994 VCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGgAVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAIG 1073
Cdd:cd22375  289 ACAQYYNGIMVLPGVADAERMAMYTGSLIGGMALGGLTS-AAAIPFSLALQARLNYVALQTDVLQENQKILAASFNKAMT 367
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1074 NITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLIT 1153
Cdd:cd22375  368 NIVDAFTGVNDAITQTSQAIQTVATALNKIQDVVNQQGNALNHLTSQLRQNFQAISSSIQAIYDRLDTIQADQQVDRLIT 447
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1154 GRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYETVTAW 1233
Cdd:cd22375  448 GRLAALNAFVSQTLTKYTEVRASRQLAQQKVNECVKSQSNRYGFCGNGTHIFSIVNAAPEGLVFLHTVLLPTQYKDVEAW 527
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1234 AGICAldgDRTFGLVVKDVQLTLFRNlDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYIDINQT 1313
Cdd:cd22375  528 SGLCV---DGVNGYVLRQPNLALYKD-GGVFRITSRVMFEPRIPTMADFVQIENCNVTFVNISRSELQTIVPEYVDVNKT 603
                        650       660       670       680       690       700       710
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 267339   1314 VQDILENFrPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIETYVK 1388
Cdd:cd22375  604 LQELIEKL-PNYTVPDLDLDQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWLNRVETYIK 677
delta-PDCoV-like_Spike_SD1-2_S1-S2_S2 cd22373
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
684-1371 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine coronavirus HKU15, avian coronaviruses, and related deltacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine coronavirus PDCoV, and several avian coronaviruses such as quail deltacoronavirus (QdCoV) UAE-HKU30, white-eye coronavirus HKU16, common moorhen coronavirus HKU21, thrush CoV HKU12, and munia CoV HKU13, all from the Buldecovirus subgenus of deltacoronaviruses. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411960 [Multi-domain]  Cd Length: 648  Bit Score: 817.54  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    684 DSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITSINSELLG 763
Cdd:cd22373    1 DVCTDYTIYGVSGTGIIKPSDLQLHNGIAFTSPTGELYAFKNITTGKTYQVLPCETPSQLIVINNTIVGAITSSNSTENG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    764 LTHWTTTPNFYYYSiyNYTNdmtrgtaidsndVDC-EPVITYSNIGVCKNGALVFINVTH-SDGDVQPISTGNVTIPTNF 841
Cdd:cd22373   81 FTTTIVTPTFYYST--NATS------------FNCtKPVLSYGPISVCSDGAIVGTSTLQdTRPSIVSLYDGEVEIPSAF 146
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    842 TISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSMLFVSENALKLASVEAFN 921
Cdd:cd22373  147 TLSVQTEYLQVQAEQVVVDCPQYVCNGNSRCLQLLAQYTSACSNIESALHSSAQLDSREITNMFQTSTQSLELANITNFK 226
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    922 SSETLdpiykewpniggswleglKYILPSdnsKRKYRSAIEDLLFSKVVTSGLGTVDEDYKRCTGGYDIADLVCAQYYNG 1001
Cdd:cd22373  227 GDYNF------------------TSILTT---KIGGRSAIEDLLFNKVVTNGLGTVDQDYKSCSKDMAIADLVCSQYYNG 285
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1002 IMVLPGVANADKMTMYTASLAGGITLGALGGGAvAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAIGNITQSFGK 1081
Cdd:cd22373  286 IMVLPGVVDAEKMAMYTGSLTGAMVFGGLTAAA-AIPFSTAVQARLNYVALQTNVLQENQKILAESFNQAVGNISLALSS 364
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1082 VNDAIHQTSRGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLITGRLTALNA 1161
Cdd:cd22373  365 VNDAIQQTSEALNTVANAINKIQTVVNQQGEALSHLTAQLSNNFQAISTSIQDIYNRLDEVEANQQVDRLITGRLAALNA 444
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1162 FVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYETVTAWAGICaLDG 1241
Cdd:cd22373  445 YVTQLLNQMSQIRQSRLLAQQKINECVKSQSSRYGFCGNGTHLFSITQAAPNGIFFMHAVLVPTKFTRVNASAGIC-VDN 523
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1242 DRTFGLvvkDVQLTLFrNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYIDINQTVQDILENF 1321
Cdd:cd22373  524 TKGYSL---QPQLILY-QFNNSWRVTPRNMYEPRLPRQADFIPLTDCSVTFYNTTAADLPNIIPDYVDVNQTVSDIIDNL 599
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|
gi 267339   1322 rPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNIN 1371
Cdd:cd22373  600 -PTPTPPQLDVDIYNNTILNLTQEINDLQERSKNLSQIADRLQQYIDNLN 648
CoV_S2 pfam01601
Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic ...
833-1388 0e+00

Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic 'corona' after which the group is named. The Spike glycoprotein is translated as a large polypeptide that is subsequently cleaved to S1 pfam01600 and S2,. The S2 subunit normally contains multiple key components, including one or more fusion peptides (FP), a second proteolytic site (S2') and two conserved heptad repeats (HRs), driving membrane penetration and virus-cell fusion. The HRs can trimerize into a coiled-coil structure built of three HR1-HR2 helical hairpins presenting as a canonical six-helix bundle and drag the virus envelope and the host cell bilayer into close proximity, preparing for fusion to occur.


Pssm-ID: 460263  Cd Length: 502  Bit Score: 767.20  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      833 GNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSMLFVSENAL 912
Cdd:pfam01601    1 GNISIPTNFTISVQTEYIQTTSPKVSVDCAQYVCNGNERCLQLLVQYGSFCSTIEQALQGSARLEDVEVLSMLSISNRAL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      913 KLASVEAFNSSEtldpiykewpniggswleGLKYILPSDNSkrkYRSAIEDLLFSKVVTSGLGTVDeDYKRCTGGYDIAD 992
Cdd:pfam01601   81 TLATISNFGSDF------------------NFSSFLPCLNS---GRSAIEDLLFDKVVTSGLGTVD-AYKKCTKGTSIAD 138
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      993 LVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGGAVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAI 1072
Cdd:pfam01601  139 LVCAQYYNGIMVLPGVVDAEKMAMYTASLTGGMAFGGLTGAAAAIPFALAVQARLNYLGLQTDVLQENQKILANAFNNAV 218
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339     1073 GNITQsfgkvndaihqtsrGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLI 1152
Cdd:pfam01601  219 GNITD--------------GFTTTASALSKIQDVVNANAQALNQLTQQLSNNFGAISSSIQDIYSRLDQLEADAQVDRLI 284
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339     1153 TGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYETVTA 1232
Cdd:pfam01601  285 NGRLAALNAFVTQQLTKASEVKASRQLAQQKVNECVKSQSSRYGFCGNGTHLFSLPQAAPNGIMFLHTVLVPTEYITVKA 364
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339     1233 WAGICAldgDRTFGLVVKDVQLTLFRNldDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYIDINQ 1312
Cdd:pfam01601  365 TPGLCV---NGTTGYAPRDGQFVLNNT--SNWYITPRNMYQPRPITGSDFVQISSCDVNFVNITNTKLPPLIPDYVDFNK 439
                          490       500       510       520       530       540       550
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 267339     1313 TVQDILENFrpNWTVPELTFDIFNATYLNLTGEIDDLEfrseklhnttvELAILIDNINNTLVNLEWLNRIETYVK 1388
Cdd:pfam01601  440 ELEDIYKNL--NSTLPDLDLDIFNATILNLTDEIKDLE-----------RLQELIDNLNQTLVDLEWLNRYETYIK 502
CoV_Spike_S1-S2_S2 cd21698
S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model ...
804-1366 0e+00

S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model represents the S1/S2 cleavage region and the S2 subunit of the spike (S) glycoprotein from coronavirus (CoVs), including three highly pathogenic human CoVs, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect S1 and S2. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV, and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related CoVs. The S1/S2 cleavage region and the S2 fusion subunit play an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411955 [Multi-domain]  Cd Length: 523  Bit Score: 660.26  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    804 YSNIGVCKNGALVFINVTH-SDGDVQPISTGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSA 882
Cdd:cd21698    1 YGGICICYDGAIYTVSTGQeESPSIVAISTENIAIPSNFTLSVTTEYLQVTMTKVSVDCTTYVCGGSPRCKNLLLQYGSA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    883 CQTIEQALAVGARLENMEVDSMLFVSENALKLASVEAFNSSEtldpiykewpniggswlegLKYILPSDNSKRKyRSAIE 962
Cdd:cd21698   81 CDTIEQALRGIAVLEDSEVSNMFSTSKQALKLAIIKSFGGFN-------------------FSQILPTPSRPSG-RSAIE 140
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    963 DLLFSKVVTSGLGTVDeDYKRCTGGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGgAVAIPFAVA 1042
Cdd:cd21698  141 DLLFTKVVTAGLGTVD-QYKNCTKGIAIADLACAQYYNGIMVLPPVADAEKMAMYTGSLTAGMVFGGITA-AAAIPFSLA 218
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1043 VQARLNYVALQTDVLNKNQQILASAFNQAIGNITQSFGKVNDAihqtsrglatvakaLAKVQDVVNTQGQALSHLTVQLQ 1122
Cdd:cd21698  219 MQARLNYVGLQQNVLLENQKLLANSFNKAIGNISDAFSSTSSA--------------LQKIQDVVNQQAQALNTLTSQLS 284
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1123 NNFQAISSSISDIYNRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGT 1202
Cdd:cd21698  285 NNFGAISSSIQDIYQRLDKLEADVQVDRLITGRLAALNAFVTQQLIKAAEVRQSRRLAQQKINECVKSQSSRYGFCGNGT 364
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1203 HLFSLANAAPNGMIFFHAVLLPTAYETVTAWAGICAldgDRTFGLvVKDVQLTLFRNLdDKFYLTPRTMYQPRVATSSDF 1282
Cdd:cd21698  365 HLFSIPQSAPSGIVFLHTVLVPTSYKNVTAYPGICV---DGKAGS-PLEGPLVFIQNN-NHWFVTPRNMYEPRIITTADF 439
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1283 VQIEGCD--VLFVNATLSDLPsIIPDYIDINQTVQDILENFrPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTT 1360
Cdd:cd21698  440 VQITSCDanVTIVNNTVNLDP-VIPDYVDVNEELDDYIQNL-PNHTLPDLDLSGYNATILNISSEIDRLNEVAKNLNQSV 517

                 ....*.
gi 267339   1361 VELAIL 1366
Cdd:cd21698  518 VELQEY 523
gammaCoV_Spike_SD1-2_S1-S2_S2 cd22372
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
680-1380 2.50e-163

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from avian infectious bronchitis coronavirus (IBV) and related gammacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from gammacoronaviruses, including avian infectious bronchitis virus, and Beluga whale coronavirus SW1 (whale-CoV SW1). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411959 [Multi-domain]  Cd Length: 661  Bit Score: 506.83  E-value: 2.50e-163
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    680 VLHLDSCTDYNIYGRSGVGIIrqTNRT---------LLSGLYYTSLSGDLLGFKNVSDGVI--YSVTPC-DVSAQAAVID 747
Cdd:cd22372    3 NITLNKCVDYNIYGRVGQGFI--TNVTdsaadynylADGGLAILDTSGAIDIFVVQGEYGLnyYKVNPCeDVNQQFVVSG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    748 GTIVGAITSINSellglTHWTTTPNFYYYSIYNYTNdmTRGTAIDSNDVDCePVITYSNIGVCKNGALVFINVTHSDGDV 827
Cdd:cd22372   81 GNLVGILTSRNE-----TGSQLLENQFYIKLTNGTR--RRRRSISENVTSC-PYVSYGKFCIKPDGSISTIVPQELETFV 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    828 QPI--STGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVdsml 905
Cdd:cd22372  153 APLlnVTENVLIPNSFNLTVTDEYIQTRMDKVQINCLQYVCGNSLECRKLFQQYGPVCDNILSIVNSVNQKEDMEL---- 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    906 fvsenalkLASVEAFNSSETLDPIYKEWpNIGGSwleGLKYILPSdNSKRKYRSAIEDLLFSKVVTSGLGTVDEdYKRCT 985
Cdd:cd22372  229 --------LSFYSSTKPGGFNTPVFNNV-STGGF---NISLLLPP-PSSPQGRSFIEDLLFTKVETVGLPTDDA-YKKCT 294
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    986 GGY--DIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGItlgALGG--GAVAIPFAVAVQARLNYVALQTDVLNKNQ 1061
Cdd:cd22372  295 AGPlgFLKDLVCAQEYNGLLVLPPIITAEMQTMYTGSLVASM---AFGGitAAGAIPFATQIQARINHLGITQSLLLKNQ 371
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1062 QILASAFNQAIGNITQsfgkvndaihqtsrGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDE 1141
Cdd:cd22372  372 EKIAASFNKAIGHMQE--------------GFRSTSLALQQIQDVVNKQSAILTETMASLNKNFGAISSVIQDIYQQLDA 437
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1142 LSADAHVDRLITGRLTALNAFVSqtlTRQAE---VRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFF 1218
Cdd:cd22372  438 IQADAQVDRLITGRLSSLSVLAS---AKQAEyykVSQQRELATQKINECVKSQSNRYGFCGNGRHVLTIPQNAPNGIVFI 514
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1219 HAVLLPTAYETVTAWAGICALDGDRTFGLVVKDVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLS 1298
Cdd:cd22372  515 HFTYTPESFVNVTAIVGFCVNPANGSQYAIVPANGRGIFIQVNGTYYITARDMYMPRDITAGDIVTLTSCQANYVSVNKT 594
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1299 DLPSII-PDYIDINQTVQDILenfrpNWTVPEL-TFDIFNAT--YLNLTGEIDDLEFrseklhnttvelaiLIDNINNTL 1374
Cdd:cd22372  595 VITTFVdNDDFDFDDELSKWW-----NETKHELpDFDQFNYTipILNISNEIDRIQE--------------VIQGLNDSL 655

                 ....*.
gi 267339   1375 VNLEWL 1380
Cdd:cd22372  656 IDLETL 661
CoV_S1 pfam01600
Coronavirus spike glycoprotein S1; This family represents the spike glycoprotein (S) of ...
249-670 2.49e-158

Coronavirus spike glycoprotein S1; This family represents the spike glycoprotein (S) of coronaviruses. The spike protein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. This entry contains spike protein from both alpha and gamma coronaviruses but excludes the spike protein from beta-coronaviruses such as SARS-CoV.


Pssm-ID: 460262  Cd Length: 412  Bit Score: 484.15  E-value: 2.49e-158
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      249 SNCTDqCASYVANVFTTQPGGFIPSDFSFNNWFLLTNSSTLVSGKLVTKQPLLVNCLWPVPSFEEAASTFCFEGAG-FDQ 327
Cdd:pfam01600    2 SVCTN-CDGFPDNVFAVEEGGYIPPSFSFNNWFYLTNSSTPVDGRVVSNQPLLLNCLWPIPSLNGTTLKVYFNGSIpNGR 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      328 CNGA-VLNNTVDVIRFNLNFTTNVQSGKGATVFSLNTTGGVTLEISCYNDTVSDSSFSsygEIPFGVTDGPRYCYVLYNG 406
Cdd:pfam01600   81 CNGYsNKNGTVDAIRFNLNFTASDSVFAGAGSISLNTVGGVTYSFSCSNSSTPVGASH---QIPFGATDQPYYCFVNYNG 157
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      407 ---TALKYLGTLPPSVKEIAISKWGHFYINGYNFFSTFPIDCISFNLTTGDSDVFWTIAYTSYTEALVQVENTAITKVTY 483
Cdd:pfam01600  158 nisTTSQFVGILPPVVREIVISRYGDFYVNGYRYFSTPPLESVNFNLTSGDTSDFWTVAFANYTDVLVNINNTSIQRILY 237
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      484 CNSYVNNIKCSQLTANLNNGFYPVSSSEVGFVNKSVVLLPTFYTHTIVNITIGLGMKrSGYGQPIASTLSNITLPMQDNN 563
Cdd:pfam01600  238 CDSPLNSIKCQQLSFSLPDGFYSTSSVEVVQLPRTFVTLPKFATHSFVNLTVSVSFD-GGGGPPSLSALSEVNLTINGTN 316
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339      564 IDVYCIRSDQFSVYVHSTCKSAlwdnvfkrnctdVLDATAVIKTGTCPFSFDKLNNYLTFNKFCLSLSPVGANCKFDV-A 642
Cdd:pfam01600  317 NTSLCVNTSQFTVNLNFTCTST------------AYGYTAEIRTGTCPFSFDKLNNYLSFGSICFSLVPSGGGCTMDIvT 384
                          410       420
                   ....*....|....*....|....*...
gi 267339      643 ARTRANDQVVRSLYVIYEEGDNIVGVPS 670
Cdd:pfam01600  385 KYWNGSFVKVGSLYVSYSEGDNITGVPK 412
betaCoV_Spike_SD1-2_S1-S2_S2 cd22370
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
691-1349 1.63e-136

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses; This family contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses, including three highly pathogenic human coronaviruses (CoVs), Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411957 [Multi-domain]  Cd Length: 667  Bit Score: 435.76  E-value: 1.63e-136
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    691 IYGRSGVGIIRQTNRTLLS--GLYYTSlSGDLLGFKNVSDGVIYSVTPCdVSAQAAVI-DGTIVG---------AITSIN 758
Cdd:cd22370    1 LYGYTGTGVLTETNATFLPfqNFGYDS-NGNLIAFKDPQTNTIYTILPC-VSGPVSVItPGNNTNevavlynglNCSEVP 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    759 SELLG--LTHW----TTTPNFY-------YYSIYNYTN----DMTRGTAIdsndvdCEPVITYSNIGVCKNGA----LVF 817
Cdd:cd22370   79 SAISAvsLTPWwrvySSTSNYFdtpvgclLGAVNSSNNsyecDLPLGAGL------CASYTTQSVLRSRSVASrsirLTT 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    818 INVTHSDGDVQPISTGN--VTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALavgaR 895
Cdd:cd22370  153 MSFFAENSVDVEVAYSNfsIQIPTNFTIAVTEEFIPTTMPKVTVDCAQYVCGDSSECSNLLLQYGTFCDNINRAL----T 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    896 LENMEVDSmlfvseNALKLASveAFNSSETLDPIYKEWPNIGGSWLEGLkyilPSDNSKRKYRSAIEDLLFSKVVTSGLG 975
Cdd:cd22370  229 GVALLQDK------NQLEVFA--SVKQIVKTPAPLKDFGGFNFSSLLPC----LGSNGGSSARSAIEDLLFNKVTLADVG 296
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    976 TVdEDYKRCTGGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGG---AVAIPFAVAVQARLNYVAL 1052
Cdd:cd22370  297 FM-KQYDDCTGGSAARDLICAQSFNGLKVLPPLLTDEMIAAYTSALLGGTATSGWTFGassAAQIPFAMQMAYRFNGIGV 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1053 QTDVLNKNQQILASAFNQAIGNITQSFgkvndaihqtsrglATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSI 1132
Cdd:cd22370  376 TQQVLVENQKLIANKFNQALGSIQTGF--------------TATNSALAKLQDVVNQNAQALNTLVKQLSNNFGAISSSL 441
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1133 SDIYNRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAP 1212
Cdd:cd22370  442 NDILSRLDKLEADVQIDRLINGRLQVLQTYVTQQLIRASEIRASAQLAAQKMSECVKGQSKRVDFCGNGTHLMSFPQSAP 521
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1213 NGMIFFHAVLLPTAYETVTAWAGICaLDGDRTF---GLVVKDvqltlfrnlDDKFYLTPRTMYQPRVATSSDFVQIEGCD 1289
Cdd:cd22370  522 NGVVFLHVTYKPTSYKNVTTAPAIC-HNGKAYFpkeGVFVKN---------NNSWMFTGRNFYEPEIITTDNTFYSGSCD 591
                        650       660       670       680       690       700
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 267339   1290 VLFVNATLSDLPSIIPDYIDINQTVQDILENF-RPNWTVPELTFdiFNATYLNLTGEIDDL 1349
Cdd:cd22370  592 VNFTYVNNTVYNPLQPELDDFKAELDKFFKNHtSPDPNLGDLSG--INASFVDLQKEMDTL 650
MERS-CoV-like_Spike_SD1-2_S1-S2_S2 cd22379
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
835-1363 2.26e-101

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Middle East respiratory syndrome coronavirus and related betacoronaviruses in the C lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the merbecovirus subgenus (C lineage), including Middle East respiratory syndrome coronavirus (MERS-CoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411966 [Multi-domain]  Cd Length: 682  Bit Score: 339.85  E-value: 2.26e-101
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    835 VTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAvGARLENMEVDSMLFVSenaLKL 914
Cdd:cd22379  168 VSIPTNFSFGVTQEYIQTTIQKVTVDCKQYVCNGFEKCEQLLREYGQFCSKINQALH-GANLRQDDSVRNLFAS---IKT 243
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    915 ASVEAFNSSetldpiykewpnIGGSWLEGLKYILPSDNSKRKYRSAIEDLLFSKVVTSGLGTVdEDYKRCT--GGYDIAD 992
Cdd:cd22379  244 SQSQPLIAG------------LGGDFNLTLLEPPSISTGSRSYRSAIEDLLFDKVTIADPGYM-QGYDECMkqGPPSARD 310
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    993 LVCAQYYNGIMVLPGVANADKMTMYTASLAGGITLGALGGG---AVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFN 1069
Cdd:cd22379  311 LICAQYVAGYKVLPPLYDVNMEAAYTSSLLGSIAGAGWTAGlssFAAIPFAQSIFYRLNGVGITQQVLSENQKLIANKFN 390
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1070 QAIGNItqsfgkvndaihQTsrGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVD 1149
Cdd:cd22379  391 QALGAM------------QT--GFTTTNLAFQKVQDAVNANAQALSKLASELSNTFGAISSSIGDILKRLDVLEQEAQID 456
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1150 RLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYET 1229
Cdd:cd22379  457 RLINGRLTSLNAFVAQQLVRSETAARSAQLAKDKVNECVKSQSKRNGFCGQGTHIVSFVINAPNGLYFFHVGYVPTNHVN 536
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1230 VTAWAGICALDGDRTF-----GLVVKDVQLTlfrnLDDKFYLTPRTMYQPRVATSSDFVQIEGcDVLFVNATLSDLPSII 1304
Cdd:cd22379  537 VTAAYGLCDSANPTNCiapvnGYFIKNNTTR----IVDEWSYTGSSFYAPEPITSANTRYVSP-DVTFQNLSNNLPPPLL 611
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 267339   1305 PDYIDInqTVQDILENFRPNWTVPELTF---DIFNATYLNLTGEIDDLEFRSEKLHNTTVEL 1363
Cdd:cd22379  612 SNSTDI--DFKDELEEFFKNVSSQIPNFgsiSQINTTLLDLSDEMLSLQQVVKALNESYIDL 671
bat-HKU9-CoV-like_Spike_SD1-2_S1-S2_S2 cd22381
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
691-1400 3.09e-101

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Rousettus bat coronavirus HKU9 and related betacoronaviruses in the D lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the nobecovirus subgenus (D lineage), including Rousettus bat coronavirus HKU9 (Ro-BatCoV HKU9). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411968 [Multi-domain]  Cd Length: 731  Bit Score: 340.96  E-value: 3.09e-101
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    691 IYGRSGVGIIRQTNRTLLSG-LYYTSLSGDLLGFKnvSDGVIYSVTPCdVSAQAAVidgtivGAITSINSELL--GL--- 764
Cdd:cd22381    1 LYGYTGTGVLSTSNLTIPDSkVFSASSTGDIIAVS--VNGTVYSISPC-VSVPISV------GYDPGFERALLfnGLscs 71
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    765 -----------THWTT-----------TPNFYYYSIYNYTNDMTRGTAIDSNDVDC-EPVITYSNIGVCKNG-ALVFINV 820
Cdd:cd22381   72 eraravsepasDYWRAsvsdganntfdTPSGCVYNVINRTTITVNQCSMPLGNSLClVNNTTAVSARGSLSLlSLVTYDP 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    821 ThSDGDVQPIS-TGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAvgarlenm 899
Cdd:cd22381  152 L-YDSSVTPLTpVYWVSIPTNFTLAATTEYIQTTAPKINIDCAKYLCGDSSRCLTVLLQYGTFCDDVNKALA-------- 222
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    900 EVDSMLFvsenalklASVEAFNSSETLDPIYKEWPNIGGSW-LEGLKYILPSDNSKRKYRSAIEDLLFSKVVTSGLGTVD 978
Cdd:cd22381  223 RVSTILD--------ASLVSLVSELTSDVVRSENLAFDGDYnFTGLMGCLGSNCNSKSYRSALSDLLYNKVKVADPGFMQ 294
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    979 EdYKRCTG---GYDIADLVCAQYYNGIMVLPGVANADKMTMYTASLAGGI-----TLGALGGGAvaIPFAVAVQARLNYV 1050
Cdd:cd22381  295 S-YQKCIDsqwGGNIRDLICTQTFNGISVLPPIVSPGMQALYTSLLVGAVassgyTFGITSVGV--IPFATQLQFRLNGL 371
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1051 ALQTDVLNKNQQILASAFNQAIGNITQSFGKVNdaihqtsrglatvaKALAKVQDVVNTQGQALSHLTVQLQNNFQAISS 1130
Cdd:cd22381  372 GVTTQVLVENQKLIANSFNKALVSIQKGFDATN--------------QALSKMQTVINQHAQQLQTLVQQLGNSFGAISS 437
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1131 SISDIYNRLDELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANA 1210
Cdd:cd22381  438 SINEIFSRLDGLEANAEVDRLINGRMVVLNTYVTQLLIQASEVRAQAALAKQKISECVKAQSLRNDFCGNGTHVLSIPQL 517
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1211 APNGMIFFHAVLLPTAYETVTAWAGICaLDGDrtfGLVVKDvQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDV 1290
Cdd:cd22381  518 APNGVLFIHYSYQPTAYALVQTAAGLC-FNGT---GYAPRG-GLFVLPNNSNLWHFTKMNFYNPVNISYSNTQVLTSCSV 592
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1291 LFVNATLSDLPSIIPDYIDINQTVQDILENFRpnwTVPELTFD--IFNATYLNLTGEIDDLefrseklhnTTVelailID 1368
Cdd:cd22381  593 NYTTVNYTVLNPSEPSDFNFQEEFDKWYKNQS---SQFNNTFNpsDFNFSTVDVNEQLATL---------TDV-----VK 655
                        730       740       750
                 ....*....|....*....|....*....|....*..
gi 267339   1369 NINNTLVNLEWLNRIETYVKWPWYVWL-----LIGLV 1400
Cdd:cd22381  656 QLNESFIDLKKLNVYEQTIKWPWYVWLamiagLVGLA 692
alphaCoV-HKU2-like_Spike_SD1-2_S1-S2_S2 cd22371
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV ...
698-1409 9.44e-98

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV spike (S) glycoprotein from Rhinolophus bat coronavirus HKU2 and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Wencheng shrew coronavirus (WESV), Lucheng Rn rat coronavirus (LRNV), and two bat viruses (Rhinolophus bat coronavirus HKU2 and BtRf-AlphaCoV/YN2012). Members of this group form a distinct cluster that is separated from the other alphacoronaviruses. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411958 [Multi-domain]  Cd Length: 686  Bit Score: 329.83  E-value: 9.44e-98
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    698 GIIRQTNRTLLSglYYTSL-SGDLLGFKNVsDGVIYSVTPC-----DVSAQAAVIDGTIvgaitsINSELLGLTHwtTTP 771
Cdd:cd22371    8 GILYETNFTFDS--FYNLLyKGSMVKYVRI-LGVVYEVEPCnefsySVLKNNSSSYGTL------YSGADCNQID--TKT 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    772 NFYYYSIYNYTND----MTRGTAIDSNDVDCEPVITYSNIGVCKNGALV---FINVTHSDGDVQPIST-GNVTIPTNFTI 843
Cdd:cd22371   77 FRFKARSHTGTNTslgcLFNASYTNDTYTTCLNPLGNGFCADVNVTSPVvgnIGIQKHDTDYVRPILTeQFIELPLDHQL 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    844 SVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAVGARLENMEVDSML--FVSENALKLASVEAFN 921
Cdd:cd22371  157 VVKEQFLQTSMPKFDVDCERYICDVSKACRELLFKYGGFCSKITADIKGSSILLDSQILGLYktIAVDFSSPDVDFGDFN 236
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    922 SSETLDPiykewpniggswleglkyilpsdnskRKYRSAIEDLLFSKVVTSGLGTVDeDYKRCTGGyDIADLVCAQYYNG 1001
Cdd:cd22371  237 FSMFMSE--------------------------KNGRSFIEDLLFDKIVTTGPGFYQ-DYYDCKKM-NLQDLTCAQYYNG 288
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1002 IMVLPGVANADKMTMYTASLAGGITLGALGGGAVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQaignITQSFGK 1081
Cdd:cd22371  289 IMVIPPIMDDETIGMYGGIVAASMTAGLFGGQAGMVTWNTAMAGRLNALGVTQDALVEDVNKLANGFNN----LTQSVSK 364
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1082 vndaihqtsrGLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLITGRLTALNA 1161
Cdd:cd22371  365 ----------LAKTTSQALSAIQAVVNQNAAQVEQLVQGLSENFGAISNNFEVIAERLEKLEADQQMDRLINGRMNVLQN 434
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1162 FVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYETVTAWAGICALDG 1241
Cdd:cd22371  435 FVTNYKLKISELKSTQRLVQSLINECVYAQSLRNGFCGDGLHVMSLMQNAPDGIMFFHYTLKPNNTIIVKTTPGLCLSNE 514
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1242 DRTFGLVVKDVQLTLFRnlDDKFYLTPRTMYQPRVATSSDFVQIE-GCDVLFVNAT-----LSDLPSIIPDYIDINQTVQ 1315
Cdd:cd22371  515 VCIKPIDAKFGVLVSAN--DSYWHFTPRNIYNPENITNSNIIAVSgGANYTTVNNTidiiePPQNPPIDEEFRELYKNVT 592
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1316 DILENFRpnwtvpELTFDIfnaTYLNLTGEIDDLEfrseklhnttvELAiliDNINNTLVNLEWLNRIETYVKWPWYVWL 1395
Cdd:cd22371  593 LELEQLK------NITFDM---SKLNLTYEIDRLN-----------EIA---ENVSKLHVTVSEFNKYVQYVKWPWYVWL 649
                        730
                 ....*....|....
gi 267339   1396 LIGLVVIFCIPLLL 1409
Cdd:cd22371  650 AIFLVLILFSFLML 663
HKU1-CoV-like_Spike_SD1-2_S1-S2_S2 cd22380
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
837-1363 2.88e-95

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from human HKU1 and OC43 coronaviruses and related betacoronaviruses in the A lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the embecovirus subgenus (A lineage), including highly pathogenic human coronaviruses (CoVs), HKU1 and OC43 CoVs, as well as murine hepatitis virus (MHV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of MHV is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411967 [Multi-domain]  Cd Length: 663  Bit Score: 322.11  E-value: 2.88e-95
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    837 IPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAvgarlenmEVDSMLFVSENALKLAS 916
Cdd:cd22380  167 IPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILN--------EVNELLDTTQLQVANSL 238
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    917 VEAFNSSETL-DPIYKEWPNIGGSWLEGlkyILPSDNSKRKYRSAIEDLLFSKVVTSGLGTVdEDYKRCTGGYDIADLVC 995
Cdd:cd22380  239 MQGVTLSSRLkDGINFNVDDINFSPVLG---CLGSDCNAASSRSAIEDLLFDKVKLSDVGFV-EAYNNCTGGAEIRDLLC 314
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    996 AQYYNGIMVLPGVANADKMTMYTASlAGGITLGALGGGAVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAIGNI 1075
Cdd:cd22380  315 VQSFNGIKVLPPVLSENQISGYTTA-ATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAI 393
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1076 TQSFGKVNdaihqtsrglatvaKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAHVDRLITGR 1155
Cdd:cd22380  394 QEGFDATN--------------SALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGR 459
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1156 LTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHAVLLPTAYETVTAWAG 1235
Cdd:cd22380  460 LTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPG 539
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1236 ICaLDGDRtfGLVVKDvqlTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATLSDLPSIIPDYIDINQTVQ 1315
Cdd:cd22380  540 LC-IAGDR--GIAPKS---GYFVNVNNEWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELD 613
                        490       500       510       520
                 ....*....|....*....|....*....|....*....|....*....
gi 267339   1316 DILENfrPNWTVPELTFDIF-NATYLNLTGEIDDLEFRSEKLHNTTVEL 1363
Cdd:cd22380  614 QWFKN--QTSVAPDLSLDEYiNVTFLDLQDEMNRIQEAIKVLNESYINL 660
SARS-CoV-like_Spike_SD1-2_S1-S2_S2 cd22378
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
693-1384 3.68e-93

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the sarbecovirus subgenus (B lineage), including highly pathogenic human CoVs such as Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS-CoV-2 (also known as a 2019 novel coronavirus or 2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related coronaviruses. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411965 [Multi-domain]  Cd Length: 662  Bit Score: 316.17  E-value: 3.68e-93
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    693 GRSGVGIIRQTNRTLLSglyYTSLSGDLLGFknvSDGV-------IYSVTPCDVSAQAAVIDGTIVGAITSINSELLGLT 765
Cdd:cd22378    3 GLTGTGVLTPSSKRFQP---FQQFGRDVSDF---TDSVrdpktleILDISPCSFGGVSVITPGTNASSEVAVLYQDVNCT 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    766 HWTT-------TPNFYYYSIYNYTNDMTRGTAI----DSNDVDCEPVI------TYSNIGVCK-NGALVFINVTHSDGDV 827
Cdd:cd22378   77 DVPTaihadqlTPAWRVYSTGSNVFQTQAGCLIgaehVNTSYECDIPIgagicaSYHTVSLLRsTSQKSIVAYTMSLGAE 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    828 QPISTGN--VTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAvGARLENMEVDSML 905
Cdd:cd22378  157 NSIAYSNnsIAIPTNFSISVTTEVMPVSMAKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALS-GIAVEQDKNTQEV 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    906 FvsenalklASVEAfnssetldpIYKEwPNIGGSWLEGLKYILPsDNSKRKYRSAIEDLLFSKVVTSGLGTVDEdYKRCT 985
Cdd:cd22378  236 F--------AQVKQ---------MYKT-PTIKDFGGFNFSQILP-DPSKPTKRSFIEDLLFNKVTLADAGFMKQ-YGDCL 295
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    986 GGYDIADLVCAQYYNGIMVLPGVANADKMTMYTASL-----AGGITLGAlgGGAVAIPFAVAVQARLNYVALQTDVLNKN 1060
Cdd:cd22378  296 GDINARDLICAQKFNGLTVLPPLLTDEMIAAYTAALvsgtaTAGWTFGA--GAALQIPFAMQMAYRFNGIGVTQNVLYEN 373
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1061 QQILASAFNQAIGNITQSfgkvndaihqtsrgLATVAKALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLD 1140
Cdd:cd22378  374 QKQIANQFNKAISQIQES--------------LTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLD 439
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1141 ELSADAHVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHA 1220
Cdd:cd22378  440 KVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQAAPHGVVFLHV 519
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1221 VLLPTAYETVTAWAGICAlDGDRTF---GLVVKDvqltlfrnlDDKFYLTPRTMYQPRVATSSDFVQIEGCDVL--FVNA 1295
Cdd:cd22378  520 TYVPSQERNFTTAPAICH-EGKAYFpreGVFVSN---------GTSWFITQRNFYSPQIITTDNTFVSGNCDVVigIINN 589
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339   1296 TLSDlpSIIPDYidinQTVQDILENFRPNWTVPELTF-DI--FNATYLNLTGEIDDLEfrseklhnttvELAiliDNINN 1372
Cdd:cd22378  590 TVYD--PLQPEL----DSFKEELDKYFKNHTSPDVDLgDIsgINASVVNIQKEIDRLN-----------EVA---KNLNE 649
                        730
                 ....*....|..
gi 267339   1373 TLVNLEWLNRIE 1384
Cdd:cd22378  650 SLIDLQELGKYE 661
CoV_S1_C pfam19209
Coronavirus spike glycoprotein S1, C-terminal; This entry represents a domain found at the ...
684-740 1.33e-21

Coronavirus spike glycoprotein S1, C-terminal; This entry represents a domain found at the C-terminus of the Coronavirus S1 protein. It is found across a range of alpha, beta and gamma coronaviruses. This small all beta stranded domain is known as subdomain 2 in the structure of the porcine epidemic diarrhea virus spike protein.


Pssm-ID: 437047 [Multi-domain]  Cd Length: 57  Bit Score: 89.22  E-value: 1.33e-21
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 267339      684 DSCTDYNIYGRSGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVS 740
Cdd:pfam19209    1 NVCTDYTIYGITGTGVIRETNSTIPSGLYYTSSSGDLLGFKNSTTGTVYSVTPCVSS 57
PHA03332 PHA03332
membrane glycoprotein; Provisional
1008-1193 8.48e-03

membrane glycoprotein; Provisional


Pssm-ID: 223047 [Multi-domain]  Cd Length: 1328  Bit Score: 40.72  E-value: 8.48e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    1008 VANADKMT---MYTASLAGGI-TLGALGGGAVAIPFAVAVQARLNYvALQTDVLNKNQQILAsafnqaigniTQSFGKVN 1083
Cdd:PHA03332  829 VLDLWHETvkmFAPRRFGGSVmAGDAIGLSAAAFTMASAALNAATQ-ALAVATLYVNQLLQA----------TAATAEMA 897
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 267339    1084 DAIHQTSRglatvakALAKVQDVVNTQGQALSHLTVQLQNNFQAISSSISDIYNRLDE--LSADAHVDRLITGrLTALNA 1161
Cdd:PHA03332  898 SKIGGLNA-------RVDKTSDVITKLGDTIAKISATLDNNIRAVNGRVSDLEDQVNLrfLAVATNFNTLATQ-LKELGT 969
                         170       180       190
                  ....*....|....*....|....*....|..
gi 267339    1162 FVSQTLTRQAEVRASRQLAKDKVNECVRSQSQ 1193
Cdd:PHA03332  970 TTNERIEEVMAAALYYQQLNSLTNQVTQSASK 1001
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH